NCT00001835View on ClinicalTrials.gov

Oxaliplatin in Cancer Patients With Impaired Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 1999

Study Completion Date

December 31, 2001

Conditions
Kidney DiseaseNeoplasmNeoplasm Metastasis
Interventions
DRUG

Oxaliplatin

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001835 - Oxaliplatin in Cancer Patients With Impaired Kidney Function | Biotech Hunter | Biotech Hunter